How organ growth is regulated to achieve proper scaling with final body size has been a long standing question in developmental biology. Organ growth is a dynamic process that is finely tuned by highly conserved signaling molecules that are produced and act within the tissue of origin (intrinsic) or on a distant tissue (extrinsic) (Boulan et al., 2015; Hariharan, 2015; Johnston and Gallant, 2002; Mirth and Shingleton, 2012) . These growth signals regulate final organ size through three distinct processes: cell division (proliferation), mass accumulation (cell growth) and cell death (apoptosis). The Drosophila wing imaginal disc, the larval precursor to adult wings and thorax, has been widely used as a model to study the molecular mechanisms that control organ growth and size control (Martin et al., 2009) . Genetic analysis has identified numerous wing disc intrinsic factors, such as Wnt, Hedgehog, and Bone Morphogenetic Protein (BMP) homologs, that are required for proper patterning and proliferation (Hariharan, 2015) . In contrast, examples of extrinsic factors that regulate imaginal disc growth are limited. The Insulin-like signaling pathway is one clear exception. Insulin-like peptides are produced in the brain and fat body and are well known to promote both growth and proliferation in many tissues including imaginal disc cells (Boulan et al., 2015; Droujinine and Perrimon, 2013; Grewal, 2012; Nijhout, 2003; Shingleton et al., 2007; Sopko and Perrimon, 2013; Teleman, 2009 ). Insulin-like factors act in a physiological capacity to coordinate overall organismal growth with nutrition. Identification of other extrinsic growth signals could provide new insights into mechanisms governing coordinated organ scaling.
The largest and most diverse group of signaling molecules is the Transforming Growth Factor β (TGFβ) superfamily of growth and differentiation factors. The superfamily is divided into the BMP and the Activin/TGFβ-like subfamilies based on sequence and signaling relationships. In higher vertebrates, these growth factors play a myriad of roles during development from cell fate specification and stem cell maintenance to control of cellular growth and proliferation (Morikawa et al., 2016) . Both TGFβ branches are conserved in Drosophila, where limited functional redundancy and a powerful genetic toolkit provide an attractive system for study (Peterson and O'Connor, 2014; Upadhyay et al., 2017) . The Drosophila BMP ligand Decapentaplegic (Dpp) functions as a classic intrinsic morphogen, since it is secreted from a limited number of imaginal disc source cells and then diffuses throughout the tissue to regulate proliferation and patterning based on its concentration gradient (Campbell and Tomlinson, 1999; Lecuit et al., 1996; Restrepo et al., 2014) . Conversely, the Activin-like branch also plays a significant role in disc growth, however it is much less characterized (Brummel et al., 1999; Hevia and de Celis, 2013; Hevia et al., 2017) .
In Drosophila, Activin-like signaling is initiated by the three ligands, Myoglianin (Myo), Activinβ (Actβ), and Dawdle (Daw). These ligands bind to and activate a hetero-tetrameric receptor complex on the cell membrane consisting of two type-I receptor subunits encoded by the baboon (babo) locus and two type-II receptor subunits encoded by either the punt or wishful-thinking (wit) genes or perhaps a combination of the two (Upadhyay et al., 2017) . Activated Babo phosphorylates cytosolic dSmad2 which then accumulates in the nucleus and, along with the co-Smad Medea, regulates expression of target genes (Brummel et al., 1999; Hevia et al., 2017) .
Notably, there are three splice isoforms of babo with different ligand binding domains, which presumably provide ligand binding specificity (Jensen et al., 2009) . Babo null mutants die at the larvalpupal transition and have significantly smaller wing imaginal discs and escapers, produced by hypomorphic alleles, also have smaller adult wings (Brummel et al., 1999) . Conversely, expression of constitutively activated Babo in wing imaginal discs leads to larger adult wings that contain more cells, suggesting that Activin-like signaling has a role in regulating proliferation (Brummel et al., 1999; Hevia and de Celis, 2013) . Additionally, Babo can signal non-canonically through Mad (the BMP Smad) to stimulate wing disc overgrowth, but only in the background of a protein null allele of dSmad2 (Peterson and O'Connor, 2013) .
For both the dSmad2 canonical and the Mad non-canonical signaling pathways, it remains unclear which Babo isoform and which Activin-like ligands, or combination thereof, regulates disc growth, nor is it clear which tissue(s) provide the ligands that promote disc growth. Expression analysis by in situ hybridization or RNAseq data suggests that all Activin-like ligands are expressed in the imaginal wing disc, albeit at low levels, perhaps indicating collective contribution to stimulating tissue growth (Graveley et al., 2011; Hevia and de Celis, 2013) . However it is important to recognize that mRNA expression does not necessarily correlate with secretion of functional ligand, especially since TGFβ−type ligands undergo a series of post-translational modifications and ligand processing to generate active molecules and these processes may vary within different tissues (Akiyama et al., 2012) .
Here we report our analysis of Activin-like ligands and Baboon isoforms for their roles in regulating imaginal disc growth. Through a series of genetic experiments, we demonstrate that among the three Drosophila Activin-like ligands, only Myo is required for proper growth of imaginal discs. We also identify the receptors Babo-A and Punt as being necessary for Myo regulation of wing imaginal disc growth via phosphorylation of dSmad2. Surprisingly, we identify the tissue source of Myo that controls disc growth to be the larval muscle.
All Drosophila Activin-like ligands (Myo, Actβ, and Daw) have tissue specific function yet signal via the sole Type-I receptor Babo. Hence, the babo mutant phenotype is likely a composite of the three individual ligand mutant phenotypes. The imaginal discs of babo mutants are approximately 30% smaller than wild-type but do not exhibit any obvious defects in tissue patterning (Brummel et al., 1999) .
We set out to identify which Activin-like ligand(s) are required for proper imaginal disc growth. Null myo, Actβ, and daw mutants are larval or pharate lethal (Awasaki et al., 2011; Ghosh and O'Connor, 2014; Zhu et al., 2008 , Moss Taylor et al., 2019 . Therefore, we analyzed the size of imaginal wing discs from late third instar larvae of null mutant animals. For this initial analysis, we used a simple yeast/sugar diet (5Y5S), because daw mutants are sensitive to standard acidic cornmeal food (Ghosh and O'Connor, 2014) . Interestingly, only myo mutants yield significantly smaller discs, phenocopying babo mutants.
Myo wing discs are approximately 40% smaller than yw controls, but retain their normal shape and pattern (Figure 1 , B and E). Actβ mutant discs had no significant size defects, while daw mutant discs were slightly smaller, which may be attributable to the reduction of insulin secretion in the daw mutants ( Figure 1 , C-E) (Ghosh and O'Connor, 2014) . Previous studies suggested that all Activin-like ligands are expressed in the wing disc (Hevia and de Celis, 2013) . Despite this observation, our result clearly suggests that only myo is functionally required for growth of the discs, and that other ligands may have other functions apart from disc growth. We next asked whether other imaginal tissues such as the haltere and leg discs are also affected by the loss of myo. Indeed, both these imaginal discs are also approximately 40-50% smaller in myo mutants and maintain their proportional size (Figure 1 , F-I). This suggests that Myo signaling regulates tissue growth in all three of these imaginal discs to similar extents.
To determine why myo mutant discs are small, we measured cell size, cell growth, proliferation, and apoptosis. First, to assess cell size, we used phalloidin staining to mark the apical actin belt, and measured the cell density at the epithelium apical surface. We observed that the cells in myo mutants are more densely packed. We calculated that the cells in these mutants are approximately 22% smaller than controls ( Figure 1 , J-L). This observation is consistent with the smaller cell size report for dSmad2 mutant discs (Peterson and O'Connor, 2013) . Next, we checked for cell proliferation and cell death markers at 90-96 hours after egg lay (AEL ), at time at which a large amount disc growth occurs, and because cell death pathways are blocked later in development . We examined proliferation by staining for phospho-Histone 3(ser10) to mark mitotic cells, and found no significant difference between myo discs and controls at this stage ( Figure 1 , M-O). Next, we stained 90-96hr AEL discs with anti-cleaved-caspase 3, an apoptosis marker, and found no increase in apoptosis in myo mutants (Figure 1 Supplement 1, A-B).
Another possible explanation for why myo mutant discs do not grow properly could be defects in TOR pathway regulation. To address this issue, we stained growing early L3 imaginal discs for phospho-S6, which is a target of S6K and a readout of TOR pathway activation (Romero-Pozuelo et al., 2017) . We found no decrease in pS6 staining in myo mutant discs, indicating that TOR signaling is not perturbed in these cells (Figure 1 Supplement 1, C-D). We conclude that myo mutant discs are smaller in part due to smaller cells. however, the 22% decrease in cell size is insufficient to completely account for the 40-50% decrease in total tissue size. Because our proliferation and apoptosis assays are snapshot experiments of fixed tissues, we infer that the portion of final disc size that cannot be accounted for by smaller cell size represents either a small proliferation reduction or a slight increase in apoptosis rate that cannot be detected at individual time points but, over the course of the entire developmental period, leads to an additional ~20% decrease in disc size. We note that a previous study of dSmad2 mutant clones in wing discs reported smaller dSmad2 mutant average clone size compared to control clones, consistent with a reduction in proliferation rate (Hevia et al., 2017) .
Myo is homologous to vertebrate Mstn, which negatively regulates skeletal muscle size by inhibiting proliferation of muscle stem cells (Morikawa et al., 2016) and regulation of protein homeostasis Rodriguez et al., 2014; Trendelenburg et al., 2009) . Recent studies in Drosophila using RNAi tissue specific knockdown suggested that Myo also functions as a negative regulator of muscle size similarly to vertebrate Mstn (Augustin et al., 2017) . We re-examined this issue using myo null alleles and measured the size of muscles 6 and 7, as well as the number of nuclei per fiber from the 2nd Abdominal segment. Surprisingly, myo1 mutant muscles are 13% smaller vs heterozygote controls (p = 0.02), however they contain the same number of nuclei per fiber, which suggests that there were no defects in myoblast fusion during embryogenesis (Figure 1 , P-S). We repeated the experiment using a newly generated myoCR2 allele and analyzed myo1/CR2 transheterozygotes to rule out 4th chromosome background effects. In this case, we find no difference in muscle size compared to controls again indicating that myo mutants do not have larger muscles compared to heterozygote controls (Figure 1 Supplement 2). We also repeated the RNAi experiments and find no statistical difference in muscle size of mef2>myo-miRNA vs w1118; myo-miRNA controls ( Figure 1 , Supplement 2). Additionally, ubiquitous knockdown of myo using da-GAL4 does not result in larger muscles compared to the myo null mutants, or myo heterozygotes ( Figure 1 Supplement 2). Taken together our results suggest that Drosophila myo is not functionally conserved with vertebrate Mstn in regulating muscle size.
Canonical TGFβ/Activin pathway activation in Drosophila is mediated by the Type-I receptor Baboon phosphorylating cytosolic dSmad2 at the C-terminus (Brummel et al., 1999; Peterson and O'Connor, 2014; Upadhyay et al., 2017) . To determine if Myo acts through the canonical signaling pathway, we examined phosphorylated dSmad2 (p-dSmad2) levels by western blots of late L3 larvae wing disc extracts of yw, myo heterozygotes and null animals. In homozygous null mutants there is no signal under our detection conditions. These findings indicate that Myo is the primary ligand for TGFβ/Activin signaling in wing discs (Figure 1 , T-U).
Baboon is the sole Activin branch Type I receptor in Drosophila, but encodes three splice isoforms (Awasaki et al., 2011; Jensen et al., 2009) . The three splice isoforms are a result of mutually exclusive alternative splicing of the fourth exon (4a, 4b, 4c) giving rise to three receptors (Babo-A, Babo-B, and Babo-C) (Brummel et al., 1999; Jensen et al., 2009 ) that differ only in their extracellular, ligand binding domains (Figure 2 , A). It has been suggested that different tissues express different isoforms, perhaps in order to tune tissue-specific responses to various ligands (Awasaki et al., 2011; Jensen et al., 2009 ). Ectopic Myo expression in the larval brain is lethal, however viability can be partially restored by simultaneously knocking down babo-a but not babo-b or babo-c, which suggests that Myo signals via Babo-A (Awasaki et al., 2011) . Since only myo is required for proper growth of imaginal discs (Figure 1 , B), we hypothesized that babo-a should be the major splice isoform expressed in the discs. We isolated late L3 wing discs and performed qPCR analysis using isoform specific primers, and detected only baboa expression in the discs (Figure 2 , B). We verified that the primers for babo-a, babo-b and babo-c all amplify with similar efficiencies using known levels of control cDNA templates, and also found that each isoform shows different tissue-specific expression profiles (Figure 2 Supplement 1). For example, the brain primarily expresses babo-a similar to the wing disc, while the fat body and gut primarily express babo-c and the carcass (muscle and epidermis) shows mixed lower expression levels of all three isoforms.
Next, we functionally tested whether isoform Babo-A is required for wing growth using the GAL4/UAS system to conduct tissue and isoform-specific RNAi knockdown experiments. Using tissue specific and distinct GAL4 drivers such as: esg (whole disc), ci (anterior compartment), and hh (posterior compartment) GAL4 lines, we knocked down individual babo isoforms and measured overall tissue size and cell size/density. In support of the qPCR data, we find that knocking down babo-a alone with esg-GAL4 results in 40% smaller adult wings, whereas knocking down babo-b or babo-c has no effect on wing size (Figure 2 , C-F, O). We confirmed that the babo-b and babo-c RNAi constructs are active since, when expressed ubiquitously, they replicate Actβ and daw mutant phenotypes respectively. Using compartments specific Gal4 lines, we find that Ci-GAL4 driving baboa RNAi reduces the anterior compartment by 50% (Figure 2 , F-I, L). Next, knockdown of babo-a using the hh-GAL4 is pupal lethal, thus we analyzed the late L3 imaginal wing discs. To measure the size of the posterior compartment in wing discs we co-expressed GFP. Similar to the other drivers, we observed that knocking down babo-a in the posterior compartment reduced the relative size of the compartment by 35% (Figure 2 , K-N, P). Surprisingly, we also note that, for unknow reasons, the Since genetic loss of myo affected wing disc cell size, we also assessed adult cell size upon RNAi knockdown of babo-a by measuring trichome density in the adult wings. Each trichome on the wing blade arises from a single wing disc epithelial cell. Therefore, by measuring the trichome density, relative cell size can be calculated. Knockdown of babo-a using esg-GAL4 does not affect trichome density, whereas ci-GAL4 result in a 13% increase in trichome density, i.e. smaller cells (Figure 2 , Q).
Another way that cell size could be affected is by altering the thickness of the disc epithelium. If the disc epithelium is thin then the individual cells are likely smaller. Using confocal optical sectioning we observed that knocking down babo-a leads to an ~40% decrease in the epithelium thickness ( Figure 2 Previous studies have shown that Babo activates dSmad2 in numerous different tissues.
Additionally, vertebrate TGFβ/Activin type-I receptors have also been shown to cross talk with BMP R-Smads. We hypothesized that under wild type conditions, Myo/Babo signaling regulates disc growth via phosphorylation of dSmad2 but not Mad. As predicted, knocking down babo-a in the entire wing disc by simultaneously using ci-GAL4 and hh-GAL4 completely abolishes phospho-dSmad2 levels (Figure 2 , S).
Furthermore, the level of phospho-Mad in these discs is not changed (Figure 2 , T). These results indicate that in the wing disc, Babo-A activates dSmad2, not Mad, to regulate normal tissue growth.
Taken together, and assuming no difference in the number of wing disc precursors after embryogenesis, we infer that babo-a regulates tissue size by regulating both cell size and likely cell proliferation over the course of larval development. The data indicate that Babo-A is the only functional isoform in the wing imaginal disc and its removal phenocopies myo mutants in regulating wing disc growth. Thus, similar to the mushroom body neurons (Awasaki et al., 2011) , our data demonstrate that Myo signals solely through Babo-A in the wing imaginal disc.
In addition to canonical signaling, Babo can, under special circumstances, also signal noncanonically by cross-talking with downstream components of the BMP/Dpp pathway (Peterson and O'Connor, 2013) . Non-canonical Babo activity is only detectable in a protein null mutant of dSmad2 or a strong RNAi knockdown of dSmad2 (Peterson and O'Connor, 2013; Peterson et al., 2012; Sander et al., 2010) . In the absence of its preferred target dSmad2, Babo promiscuously interacts with Mad, the BMP ortholog of dSmad2, which then represses brk expression causing disc overgrowth along the anteriorposterior axis (Peterson and O'Connor, 2013) . We hypothesized that in the absence of dSmad2, noncanonical signaling (i.e. silencing of brk) is also mediated by Babo-A and not through ectopic expression of other receptor isoforms. Since Babo activity in dSmad2 loss-of-function RNAi clones results in silencing of the brk (B14-LacZ) reporter (Müller et al., 2003; Peterson and O'Connor, 2013) , we used this assay to first generate dSmad2 RNAi clones and quantified the ectopic brk-LacZ silencing To further test if non-canonical activity of Babo-A occurs throughout the wing disc, we knocked down dSmad2 in the entire disc using esg-GAL4, resulting in disc overgrowth which can be quantified by measuring the width/height ratio of the disc-pouch ( TGFβ signaling requires ligands binding to hetero-tetrameric type-I and type-II receptor complexes. There are two type-II receptors in the Drosophila genome: punt and wit, both of which can signal with Type-I receptors from either branch of the TGFβ superfamily (Upadhyay et al., 2017) . Punt is more commonly utilized during development, and facilitates Dpp signaling in the wing imaginal disc in combination with the BMP type I receptors Tkv and Sax (Brummel et al., 1994; Fuentes-Medel et al., 2012; Letsou et al., 1995; Parker et al., 2006) . In cell culture models however, Punt can also signal in combination with Babo and Activin-like ligands (Brummel et al., 1999; Jensen et al., 2009; Letsou et al., 1995) . Conversely, Wit functions primarily at the neuromuscular junction with the BMP ligand Gbb (Marqués et al., 2002) although it has been shown to bind Myo in combination with Babo in mammalian cell culture (Lee-Hoeflich et al., 2005) . Since both punt and wit are expressed in the wing imaginal disc, it is unclear whether one or both type II receptors are required for Myo-Babo signaling (Childs et al., 1993; Marqués et al., 2002) . To address this issue, we utilized the brk silencing assay in RNAi clones as described above. First, we find that knocking down both punt and wit along with dSmad2 completely rescues the ectopic brk silencing (Figure 3 , E vs F). This result indicates that one or both of these receptors is required for brk silencing in the dSmad2 RNAi clones. Next, we find that RNAi for wit does not rescue brk silencing (Figure 3 , E vs G), however RNAi for punt completely suppresses the dSmad2 RNAi induced brk silencing ( Figure 3 , E vs H). This result demonstrates that Punt signaling occurs, however it does not rule out that it may do so through Tkv, the Dpp type I receptor. To exam this issue, we knocked down tkv and dSmad2 in clones and looked for brk silencing. We find that dSmad2 RNAi silenced brk even in the absence of tkv demonstrating that Dpp and Tkv signaling is not required for this phenotype and that Babo is the primary type I receptor mediating these clonal effects. Taken together, these experiments demonstrate that Babo-A requires Punt, but not Wit, for repression of brk expression in this non-canonical signaling assay and it is likely that the same receptors are used for Myo signaling in wild type disc cells.
Growth factors such as Wg and Dpp are tissue intrinsic ligands, produced by and acting on the wing disc cells. We sought to determine if the same is true for Myo. The name myoglianin refers to the two tissues (muscles and glia) in which myo expression was initially observed (Lo and Frasch, 1999) .
More recent RNA in situ hybridization results suggested that myo is also expressed in the wing imaginal disc at low levels (Hevia and de Celis, 2013) . To precisely determine the source of Myo that acts on the wing disc, we first examined the expression pattern of myo in late L3 larvae using a myo-GAL4 reporter to drive UAS-CD8-GFP (Awasaki et al., 2011) . We detect GFP expression in both Repo+ glial cells of the brain and the ventral ganglia, as well as the larval body wall muscles (Figure 4 To determine the functional source of Myo that controls imaginal disc growth, we conducted loss-of-function studies in the dSmad2 null mutant background, and looked for suppression of the wing disc overgrowth phenotype. First, using null mutant alleles, we confirmed that loss of myo in dSmad2 mutant background suppresses the dSmad2 overgrowth, resulting in small discs similar in size to myo mutants ( Figure 4 , C-E, L). Next, we knocked down myo using tissue specific GAL4 drivers. To confirm efficacy of the RNAi constructs, we first used the da-GAL4 driver to ubiquitously knock down myo in the dSmad2 background and confirmed that it suppresses wing disc overgrowth (Figure 4 , F vs G, L).
However knocking down myo using either esg-GAL4 (wing disc) or repo-GAL4 (glia) failed to suppress the dSmad2 wing disc overgrowth (Figure 4 , F vs H, I). These results suggest that the wing discs are receiving a strong Myo signal even when myo is knocked down in the imaginal discs or glia. In contrast, RNAi knockdown of myo in body wall muscles, using either mhc-GAL4 or mef2-GAL4 drivers, completely suppresses the dSmad2 disc overgrowth phenotype phenocopying the dSmad2;myo double mutant ( Figure 4 , F vs J, K). Therefore, we conclude that muscles are the major source of Myo that stimulates imaginal disc growth.
While the suppression of disc overgrowth in a dSmad2 mutant background strongly implicates muscle as the source of ligand, we also examined if Myo expression in muscle, or other non-disc tissues, could rescue the size of myo mutant discs. First, overexpression of myo in larval muscles in wild type animals results in wings that are larger than normal (Figure 5 Supplement 1). Next, we examined whether overexpression of myo in glia, muscles, or fat body is able to rescue the size of myo mutant discs.
Overexpression in glia (repo-GAL4) results in partial rescue ( Figure 5 , C and F) while overexpression in muscle (mef2-GAL4, Figure 5 , D and F) or fat body (cg-GAL4, Figure 5 , E and F) leads to complete rescue. These results clearly demonstrate that Myo produced in distant tissues can signal to wing discs, albeit with varying degrees of signaling strength depending on the source. Collectively, these results indicate that muscle-derived Myo acts as an endocrine-like ligand via the hemolymph to activate a specific receptor complex on disc cells, consisting of Babo-A and Punt, that signals to dSmad2 to promote imaginal disc growth.
Understanding the physiologic roles of inter-organ signaling during development is an emerging and complex field. In particular, how and which inter-organ signals regulate organ/tissue growth remains an open question. In the present study, we demonstrate that the Drosophila Activin-like ligand Myoglianin is a myokine that acts systemically to fine tune imaginal disc growth. We suggest Myo tuning of disc growth may play an important role in maintaining proper allometric scaling of appendage size with the size of the muscles that control their movements.
Although Babo/dSmad2 signaling has been previously implicated in imaginal disc growth control (Brummel et al., 1999; Hevia and de Celis, 2013; Peterson and O'Connor, 2013) , the ligand(s) responsible and their production sites(s) have not been identified. Previous in situ hybridization and RNAi knockdown experiments suggested that all three Activin-like ligands (Myoglianin, Activinβ, and Dawdle) contribute to control of wing size (Hevia and de Celis, 2013) . However, we find no expression of these Activin-like ligands in imaginal discs, with the exception of Actβ which is expressed in differentiating photoreceptors of the eye imaginal disc (Moss-Taylor et al., 2019; Ting et al., 2007; Zhu et al., 2008) .
More importantly, using genetic null mutants, we show that only loss of myo affects imaginal disc size.
The discrepancy in phenotypes between tissue-specific knockdown results and the genetic nulls is often noted and not fully understood (Di Cara and King-Jones, 2016; Gibbens et al., 2011) . In addition to simple off-target effects within the wing disc itself, one possible explanation is that many GAL4 drivers are expressed in tissues other than those reported, potentially resulting in deleterious effects for the animal that indirectly affect imaginal disc size. Another possibility is that in Actβ and daw genetic null backgrounds a non-autonomous compensatory signal is generated by another tissue and this signal is not activated in the case of tissue-specific knockdown (Di Cara and King-Jones, 2016). We think both of these explanations are unlikely in this instance since we demonstrate that only the Babo-A receptor isoform is expressed and required in discs. Since we have previously shown that Daw only signals through isoform Babo-C, it is unclear why knockdown of daw in the wing disc would result in a small wing phenotype as previously reported (Hevia and de Celis, 2013; Jensen et al., 2009) . We conclude that the small wing phenotypes caused by RNAi knockdown of Actβ or daw are likely the result of off-target effects and that Myo is the only Activin-type ligand that regulates imaginal disc growth.
The signaling ability of TGFβ ligands is modulated by the specific combinations of receptors and co-receptors to which they bind (Heldin and Moustakas, 2016) . In Drosophila, the receptor requirements for effective signaling through dSmad2 likely vary for each ligand and tissue (Jensen et al., 2009) . In this report, we find that Myo signaling in the wing disc requires Punt as the type II receptor and Babo-A as the type I receptor. Furthermore, we establish that Myo is the exclusive Activin-like ligand signaling to the discs since loss of Myo eliminated detectable phosphorylation of dSmad2 in the wing imaginal disc.
Since Babo-A is the only isoform expressed in wing discs, we also conclude that Myo is able to signal through this isoform in the absence of other isoforms. Whether Myo can also signal through Babo-B or C
is not yet clear, but in the context of mushroom body remodeling Babo-A also appears to be the major receptor isoform utilized (Awasaki et al., 2011; Yu et al., 2013) . The co-receptor Plum is also required for mushroom body remodeling, suggesting that Plum and Babo-A are both necessary for efficient Myo signaling. However, it is noteworthy that Plum null mutants are viable (Yu et al., 2013) while Myo null mutants are not. This observation suggests that Plum is not required for all Myo signaling during development. Further studies will be required to evaluate whether Plum is essential to mediate Myo signaling in imaginal discs.
The requirement of Punt as a type II receptor for production of an efficient signaling complex with Myo may be context dependent. In the mushroom body, indirect genetic evidence suggests that the two Type II receptors function redundantly (Zheng et al., 2006) . Although both punt and wit are expressed in imaginal discs (Childs et al., 1993; Marqués et al., 2002) , only loss of punt produces a phenotype in the brk reporter assay. To date, we have not been able to see clear signaling in S2 cells expressing Punt and Babo-A when Myo is added. It is also notable that a previous attempt to study Myo signaling in a heterotypic cell culture model also failed (Lee-Hoeflich et al., 2005) . In that study, Myo was found to form a complex with Wit and Babo-A in COS-1 cells but no phosphorylation of dSmad2 was reported. One explanation is that effective signaling by Myo requires Punt, and Babo-A, and perhaps another unknown co-receptor that substitutes for Plum. Despite this caveat, our results provide in vivo functional evidence for a Myo signaling complex that requires Babo-A and Punt to phosphorylate dSmad2 for regulation of imaginal disc growth.
Final tissue size is determined by several factors including cell size, proliferation, death rates, and duration of the growth period. While we did observe cell size changes upon manipulation of Myo signaling, the direction of change depended on the genotype. In myo mutants, estimation of cell size via apical surface area indicates that the cells are ~20% smaller than wild-type. Although this measurement does not indicate the actual volume of the cells, it gives an indication of cell density in the epithelial sheet of the wing pouch, which is analogous to counting cells in the adult wing. RNAi knock down of babo-a in the entire disc produced smaller adult wings with larger (less dense) cells. This result differs from the myo mutant, but is similar to the reported adult wing phenotypes of babo mutants (Hevia and de Celis, 2013) and larval disc phenotypes of dSmad2 mutants (Peterson and O'Connor, 2013) . When babo-a is knocked down in one compartment, that compartment is reduced in size with smaller cells. We conclude that tissue size reduction is the consistent phenotype upon loss of Myo signaling, but cell size changes depend on the specific type of manipulation.
While cell size effects may be context dependent, it is notable that neither reduction in size of imaginal discs nor adult wing surface area can be explained solely by a cell size defect. Since we see no apoptotic increase in myo mutant discs, and because dSmad2 knockdown also fails to alter apoptotic rate (Hevia and de Celis 2013) , the mostly likely cause is an altered proliferation rate. Consistent with this view is that the large disc phenotype exhibited by dSmad2 protein null mutants is clearly dependent on Myo and we and others have previously shown that this is the result of enhanced proliferation (Peterson and O'Connor, 2013; Hevia and de Celis 2013) . Similarly earlier studies also showed that expression of activated Babo or activated dSmad2 in wing discs also leads to larger wings with slightly smaller cells which is most easily explained by an enhanced proliferation rate (Brummel et al., 1999; Hevia and de Celis, 2013) . It is worth noting that this proposed enhanced proliferation rate is difficult to detect since cell division is random with regard to space and time during development (Wartlick et al., 2011) . Thus a ~20% reduction in adult wing size caused by a proliferation defect translates into about 1/5th of disc cells dividing on average 1 fewer times throughout the entire time course of larval development. Therefore, without prolonged live imaging, this small reduction in proliferation rate will not be detectable using assays that provide only static snapshots of cell division. It is worth noting, however, that previous clonal studies also concluded that dSmad2 or Babo loss in wing disc clones resulted in a reduced proliferation rate (Hevia and de Celis, 2013) .
One attempt to shed light on the transcriptional output of TGFβ signaling responsible for wing disc size employed microarray mRNA profiling of wild-type versus dSmad2 gain-and loss-of-function wing discs (Hevia et al., 2017) . However this study did not reveal a clear effect on any class of genes including cell cycle components, and it was concluded that the size defect is the result of small expression changes of many genes. Consistent with this view are dSmad2 Chromatin Immunoprecipitation experiments in Kc cells which revealed that dSmad2 is associated with many genomic sites and thus may regulate a myriad of genes (Van Bortle et al., 2015) .
Insect myoglianin is a clear homolog of vertebrate Myostatin (Mstn/GDF8) (Hinck et al., 2016) , a TGFβ family member notable for its role in regulating skeletal muscle mass. Mstn loss-of-function mutants lead to enlarged skeletal muscles (Grobet et al., 1997; McPherron and Lee, 1997) . Mstn is thought to affect muscle size through autocrine signaling that limits muscle stem cell proliferation, as well as perturbing protein homeostasis via the Insulin/mTOR signaling pathways (Morikawa et al., 2016; Rodriguez et al., 2014) . Similarly, Gdf11, a Mstn paralog, also regulates size and proliferation of muscles and adipocytes, and may promote healthy aging (Egerman et al., 2015; McPherron et al., 2009; Sinha et al., 2014) . Mstn and Gdf11 differ in where they are expressed and function. Mstn is highly expressed in muscles during development while Gdf11 is weakly expressed in many tissues. Both molecules are found to circulate in the blood as latent complexes in which their N-terminal prodomains remain associated with the ligand domain. Activation requires additional proteolysis of the N-terminal fragment by Tolloid-like metalloproteases to release the mature ligand for binding to its receptors (Uhlén et al., 2015; Wolfman et al., 2003) . Interestingly in Drosophila, the Myoglianin N-terminal domain was also found to be processed by Tolloid-like factors, but whether this is a prerequisite for signaling has not yet been established (Serpe and O'Connor, 2006 ) . In terms of functional conservation in muscle size control, our results of both null mutants and RNAi depletion indicates that it has little effect on muscle size. This contradicts a previous study in which muscle-specific RNAi knockdown of myo was reported to produce larger muscles similar to the vertebrate observation (Augustin et al., 2017) . The discrepancy between our tissue-specific RNAi knockdown and previous studies is not clear, but our null mutant analysis strongly argues that Drosophila Myo does not play a role in muscle size control. Intriguingly however, we find that loss of Actβ, another ligand that signals through Babo and dSmad2, results in a smaller muscles (Moss-Taylor et al., 2019) contrary to that produced by loss of vertebrate Mstn and various other vertebrate Activin family members. Recent data has shown that Drosophila Actβ is the only Activin-like ligand that affects muscle growth, and it does so, in part, by regulating Insulin/Tor signaling in the opposite direction compared to vertebrates (Kim and O'Connor, 2020) . Thus, in Drosophila the Myo/Activin pathway promotes muscle growth while in vertebrates it inhibits muscle growth.
The most intriguing finding of this study is that muscle-derived Myo acts non-autonomously to regulate imaginal disc growth. This is in stark contrast to the two BMP ligands, Dpp and Gbb, which are produced by disc cells and act autonomously within the disc itself to regulate both growth and pattern (Haerry et al., 1998; Minami et al., 1999) . The fact that a TGFβ ligand can act in an endocrine-like manner is not particularly novel since many vertebrate members of the TGFβ family, including Myostatin, the closest homolog to Drosophila Myoglianin, are found in the blood (Sinha et al., 2014) .
Even the disc intrinsic molecule Dpp has been recently shown to be secreted into the hemolymph where it circulates and signals to the prothoracic gland to regulate a larval nutritional checkpoint (Setiawan et al., 2018) . Several additional reports indicate that ligands from the Drosophila Activin-like subfamily also circulate in the hemolymph and function as inter-organ signals. For example, muscle derived Actβ and Myo signal to the fat body to regulate mitochondrial function and ribosomal biogenesis, respectively (Demontis et al., 2014; Song et al., 2017) . In addition, Dawdle produced from many tissue sources can signal to the Insulin producing cells and the midgut to stimulate Insulin secretion and repress expression of sugar metabolizing genes, respectively (Chng et al., 2014; Ghosh and O'Connor, 2014) . Thus many TGFβ type factors act as both paracrine and endocrine signals depending on the tissue and process involved.
The phenotype of the myo mutant animal supports our claim that endogenous Myo contributes to imaginal disc growth. The ectopic expression assay produced various wing disc sizes when Myo was expressed in different tissues, indicating that the growth response likely depends on the level of Myo being produced in the distal tissue. Loss of glial derived Myo is not sufficient to suppress overgrowth of dSmad2 mutant discs, but overexpression of Myo in glia did partially rescue size of myo null wing discs, likely because the repo-Gal4 driven overexpression produces more ligand than endogenous glia.
Likewise, expression from a large tissue such as muscle or fat body likely produces more Myo than glia leading to normal disc growth or even overgrowth. It is also possible that Myo signaling activity is modified depending on the tissue source. Like other TGFβ family members, Myo requires cleavage by a furin protease at its maturation site to separate the C-terminal ligand from the prodomain (Lee-Hoeflich et al., 2005; Lo and Frasch, 1999) . Myo may also require a second cleavage by a Tolloid protease family member to achieve full dissociation of the prodomain from the ligand to ensure complete activation (Serpe and O'Connor, 2006) . Either of these cleavage reactions, or any other step impacting the bioavailability of active Myo ligand, may vary with tissue or may be modulated by environmental conditions.
What is the rationale for larval muscle regulating imaginal discs size? A possible reason is that for proper appendage function, the muscle and the structure (leg, wing, and haltere) that it controls should be appropriately matched to ensure optimal organismal fitness for the environmental niche the adult occupies. For example, a large muscle powering a small wing might result in diminished fine motor control. Conversely, a small muscle may not be able to power a large wing to support flight. However, the multi-staged nature of muscle and appendage development complicates this picture. Larval muscles are histolysed during metamorphosis and do not contribute to the adult muscle. However, remnants of larval muscles in the thoracic segment are preserved as fibers that act as scaffolds upon which the larval myoblasts infiltrate and fuse to become the adult indirect flight muscles (Dutta et al., 2004) . Thus, at least for the indirect flight muscles, the size of the larval muscle scaffold might contribute to the building of a bigger adult muscle. Another possibility invokes a signal relay system. Wg and Serrate/Notch signaling from the wing disc epithelial cells control myoblast proliferation during larval development (Gunage et al., 2014) . Thus it may be that Myo signaling from the larval muscles stimulates proliferation of the disc epithelial layer which in turn enhances Wnt and Serrate/Notch signaling to myoblasts to increase their number thereby coordinating the adult appendage size with muscle size. A final scenario is that, since muscle is a major metabolic and endocrine organ, Myo production may be regulated by the general metabolic state of the larva. If healthy, high levels of Myo, in concert with other growth signals such as insulin, leads to a bigger fly with large wings, and if the metabolic state is poor then lower Myo levels leads to diminished proliferation and a smaller cell size resulting in a smaller fly with small wings.
Regardless of the precise mechanism, the ability of the muscle to control appendage size has interesting implications in terms of evolutionary plasticity. The proportionality of insect wing size to body size can vary over a large range (Shingleton et al., 2008) , but the mechanism responsible for determining this particular allometric relationship for a given species is not understood. We have recently demonstrated that in Drosophila, motor neuron derived Actβ, another TGFβ superfamily member, can dramatically affect muscle/body size (Moss-Taylor et al., 2019) . Therefore, it is tempting to speculate that evolutionary forces might modulate the activity of these two genes to produce an appropriate body-wing allometry that is optimal for that species' ecological niche. is unable to rescue disc overgrowth (F vs H or I). RNAi of myo in larval muscles using mef2-GAL4 or MHC-GAL4 rescues the disc overgrowth phenotype (F vs J or K), which phenocopies ubiquitous myo RNAi (G vs J or K). (L) quantification of wing shape widening in C-K. dSmad2 wide wing is rescued by myo (C vs E) and knockdown of myo in muscles (F vs J or K). The size of muscle 6 in segment A2 is quantified. Knocking down myo in muscles using mef2-GAL4 does not significantly increase muscle size vs no GAL4 control. Knocking down myo uibiquitously using da-GAL4 does result in larger muscles, however no larger than the genetic nulls. (red squares) leads to widening with a ratio of 1.5; RNAi for babo-a (green circles) alone rescues the widening back to wild type ratio of 1.1. These discs are smaller than wild type due to loss of canonical Baboon activity (Figure 1 and 2) . There is no effect on widening by knocking down either babo-b or babo-c (blue and yellow circles vs red squares). Table   Reagent Fly strains:
TGFβ mutants: myo1, Actβ80, daw11, dSmad2F4 are described previously (Awasaki et al., 2011; Peterson and O'Connor, 2013; Serpe and O'Connor, 2006; Zhu et al., 2008) . The new myoCR2
allele is described in Kim and O'Connor, 2020 . Isoform miRNA lines for babo and myo-GAL4 are described previously (Awasaki et al., 2011) . We generated a new line of UAS-driven babo-a miRNA at the VK37 attP site using the published construct (used for Figure 2 S,T). RNAi lines for dSmad2 and tkv and the strategy used to generate new RNAi lines are described previously (Peterson and O'Connor, 2013; Peterson et al., 2012) . New RNAi lines for wit targeted 1103-1608 (NM_079953.3), and punt targeted 1069-1582 (NM_169591.1). RNAi lines for myo targeted 2259-3503 (NM_166788.2) utilizing the "snapback" gDNA/cDNA hybrid method (Kalidas and Smith, 2002) . Stocks and methods used for induction of GAL4 flp-out clones are described previously (Peterson and O'Connor, 2013 
GFP knockdown (#41554), RFP knockdown (#67852), UAS-mCD8::GFP, UAS-GFP.nls.
Primary antibodies for IHC include cleaved Caspase-3 (Cell Signaling #9661), phospho-Histone3 (S10) (Sigma, H0412), and Repo (DSHB 8D12). For B14-LacZ reporter detection, wing discs were stained with anti-β-galactosidase (Promega, #Z378A). AlexaFluor 568 or 647
(Invitrogen) conjugated secondary antibodies were used when required. Larval muscle and wing disc epithelium actin-belt were stained with rhodamine-phalloidin. To measure wing disc size, tissues were stained with DAPI. To assess brk reporter expression in clones, the red IHC signal was compared within a GFP-marked clone and a neighboring patch of control cells. Background signal was subtracted, and a ratio was calculated such that 1 indicates no change of reporter signal in the clone and lower numbers indicated repression of brk. Clones from multiple discs were selected from three regions that normally express the reporter. Signals were extracted from single Z sections using a line plot (width 5) in FIJI and visualized with the RGBProfilesTools plug-in to estimate the clone boundary.
Tissues for fluorescence microscopy were mounted with 80% Glycerol in PBS (0.1% TritonX-100). Wide-field images taken with a 20X objective on a Zeiss Axiovert microscope. CARV Confocal images were captured using a 20X objective on a Zeiss Axiovert. We also used the Zeiss LSM710 for confocal and "tile-scanning" imaging.
For adult wings, animals were dissected in 95% ethanol, and mounted with (50:50) Canadian balsam and wintergreen oil solution. Images were taken with a 4X objective (for whole wing) and 40X objective (for trichome density).
Images were processed in FIJI (imageJ). Wing disc size was calculated with the DAPI staining then using the threshold and measure functions. For larval muscle size and adult wing size, outlines were drawn using the polygon tool.
Western Blot:
Mid-late third instar larvae were dissected in cold PBS, and wing imaginal discs were collected and washed on ice. Total protein was extracted with RIPA buffer (Cell Signaling) with cOmplete protease inhibitor (Roche) and PhosSTOP phosphatase inhibitor (Roche). Lysates were mixed with reducing sample buffer, boiled, and 10 µl of sample were run on 4-12% graded precast gels (Invitrogen). Resolved protein samples were transferred to the PVDF membrane. Membrane blocking and probing were performed using standard protocols for ECL. Antibodies used for western blot: phospho-Smad2 (Cell Signaling #3108), rabbit phospho-Smad3 polyclonal affinity purified with phospho-Mad peptide (Peterson et al., 2012) , Tubulin (Sigma #T9026), goat antimouse HRP, and goat anti-rabbit HRP. phospho-dSmad2 were quantified in Fiji and normalized using tubulin or a non-specific band for loading control.
qPCR:
Late-third instar larvae were dissected in cold PBS, and tissues were pooled and washed in PBS on ice. Tissues were homogenized in Trizol (Invitrogen) and Total RNA purified using RNeasy
Mini Kit (Qiagen). cDNA libraries were made using SuperScript-III (Invitrogen). qPCR was performed using SYBR green reagent (Roche) on a LightCycler 480. Rpl23 was used as a housekeeping gene for normalization. We confirmed that primer sets for all three isoforms amplify equivalently using babo-a, b and c control cDNA templates. The following qPCR primers were used for babo isoforms:
babo-a: 